Companies don't get sold. They get bought. I'm interested to know why management wants to dump the company before going live. Do they really have $5B of value under the hood?
Biotech unicorn Stemcentrx is reportedly up for a multibillion-dollar sale
Stemcentrx turned heads last year when it came out of stealth with a $250 million funding round that gave the company a reported valuation of $5 billion. Now the biotech, backed by PayPal founder Peter Thiel, is exploring the idea of selling itself, according to The Wall Street Journal, lining up for what could be a blockbuster deal.
Join in on the conversation with David Hartmann when you subscribe to Better Business Development.